The NTRK Fusion Gene Positive Advanced Solid Tumor Market is anticipated to grow with a CAGR of nearly 5% during the forecast period 2022-2028. An NTRK fusion gene-positive cancer is a cancer in which the NTRK gene is mutated. NTRK fusions are rare and account for less than 1% of solid tumors, but the exact […]
